✦ LIBER ✦

Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood–brain barrier

✍ Scribed by Bauer, Martin; Karch, Rudolf; Neumann, Friederike; Wagner, Claudia C; Kletter, Kurt; Müller, Markus; Löscher, Wolfgang; Zeitlinger, Markus; Langer, Oliver

Book ID: 109871307
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 316 KB
Volume: 30
Category: Article
ISSN: 0271-678X
DOI: 10.1038/jcbfm.2009.265

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-response assessment of tariquidar f

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[11C]verapamil PET

✍ Martin Bauer; Markus Zeitlinger; Peter Matzneller; Johann Stanek; Edith Lackner; 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 141 KB

Dose-response assessment of tariquidar a

Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET

✍ Claudia Kuntner; Jens P. Bankstahl; Marion Bankstahl; Johann Stanek; Thomas Wane 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

Regional P-Glycoprotein Activity and Inh

Regional P-Glycoprotein Activity and Inhibition at the Human Blood–Brain Barrier as Imaged by Positron Emission Tomography

✍ Eyal, S; Ke, B; Muzi, M; Link, J M; Mankoff, D A; Collier, A C; Unadkat, J D 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 329 KB

Enhanced cerebral uptake of receptor lig

Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood–brain barrier

✍ P. Doze; A. Van Waarde; P.H. Elsinga; N.H. Hendrikse;; W. Vaalburg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Low cerebral uptake of some therapeutic drugs can be enhanced by modulation of P-glycoprotein (P-gp), an ATP-driven drug efflux pump at the blood-brain barrier (BBB). We investigated the possibility of increasing cerebral uptake of the beta-adrenergic ligands S-1'-[(18)F]-fluorocarazolol (FCAR) and

Inhibition of P-Glycoprotein: Rapid Asse

Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier

✍ Laurence Fenart; Valeric Buée-Scherrer; Laurence Descamps; Christian Duhem; Mari 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 782 KB

Development of a P-glycoprotein knockout

Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood–brain barrier

✍ Leanne Cutler; Colin Howes; Nigel J. Deeks; Tania L. Buck; Phil Jeffrey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

The objective of this study was to establish the optimal blood concentrations of the potent P-glycoprotein (P-gp) inhibitor GF120918 (Elacridar) required to achieve maximal knockout of this efflux transporter in the blood-brain barrier (BBB) of mice, rats, and guinea pigs. Genetic mdr1a/b(-/-) knock